Online access - The Antiviral Agents Bulletin Web site at www.bioinfo.com/antiviral.html includes a free database with indexing and partial text of news articles and patent abstracts from 1991-1998. A fee-based (e.g., subscription), full text database is also available at this Web site. For further information contact: Ron Rader, Biotechnology Information Institute; Phone: 301-424-0255; Fax: 301-424-0257; E-mail: biotech@bioinfo.com.
Other full text databases providing access to Bulletin news articles include: a database offered by Knowledge Express Data Systems (www.knowledgeexpress.com); the Newsletter Database on the DIALOG (file 636) and DATA-STAR systems; and the Business & Industry (B&I) database on DIALOG (file 9).
Subscribers and others desiring full sets of 1998 or other back issues (in published or computer-based formats) may contact the publisher to request information about rates and availability.
Abbott Labs. - Mar., p. 69; July, p. 193; Aug., p. 226, 237; Sep., p. 267
Advanced Viral Research Corp. - May, p. 138; June, p. 171
Affymetrix Inc. - May, p. 141
AGC - Dec., p. 365
Agouron Pharmaceuticals, Inc. - Feb., p. 41; Mar., p. 69, 72; June, p. 163; July, p. 201, 205; Aug., p. 240; Sep., p. 267; Oct., p. 299; Nov., p. 331, 333; Dec., p. 365
Agritek Bio Ingredients Corp. - Nov., p. 332
AIDS Drug Assistance Programs (ADAPs) - Dec., p. 366
AIDS Vaccine Evaluation Group (AVEG) - Feb., p. 37
Alexander Parker Pharmaceuticals, Inc. - May, p. 136
Alpha 1 Biomedicals Inc. - Mar., p. 78
AlphaVax, LLC - Dec., p. 362
Alta Natural Herbs & Supplements Ltd. - June, p. 172
Amarillo Biosciences Inc. - Apr., p. 106; May, p. 140; Nov., p. 332
AmericaŐs Blood Centers (ABC) - Aug., p. 238
American Academy of Pediatrics (AAP) - Dec., p. 364
American Home Products Corp. - May, p. 137; June, p. 170; Aug., p. 228; Sep., p. 258; Nov., p. 331
American Liver Foundation - July, p. 203
American Red Cross - Apr., p. 109; Oct., p. 300; Dec., p. 365
American Society for Microbiology - Apr., p. 109
AnorMED, Inc. - Sep., p. 267
Aphios Corp. - Nov., p. 328
Apollon, Inc. - Mar., p. 78; May, p. 137
Aquila Biopharmaceuticals, Inc. - May, p. 140
ArQule, Inc. - Mar., p. 72
Arris Pharmaceutical Corp - Aug., p. 240
Astra AG - Dec., p. 365
Avanir (use Lidak Pharmaceuticals)
AVANT Immunotherapeutics, Inc. - May, p. 139; Oct., p. 295
Aventis Hoechst - Dec., p. 359
Aventis Pharma - Dec., p. 359
Aventis Rhone-Poulenc - Dec., p. 359
Aviron, Inc. - Mar., p. 71, 73; May, p. 133; July, p. 202; Aug., p. 227; Sep., p. 262, 269
Bar-Ilan Univ. - Nov., p. 325
Bayer Group - Mar., p. 77; Oct., p. 297
BBI Biotech Research Laboratories - Aug., p. 239
BC Centre for Excellence in HIV/AIDS - Aug., p. 235
Bio-Technology General Corp. - June, p. 170
BioChem Pharma Inc. - Feb., p. 34; Mar., p. 72; Apr., p. 104, 105; May, p. 138, 141; June, p. 169, 170, 174; Aug., p. 234; Sep., p. 270; Dec., p. 353, 361
BioCryst Pharmaceuticals, Inc. - Oct., p. 296
Biogen, Inc. - Mar., p. 78; July, p. 206
BioStar, Inc. - May, p. 140; Nov., p. 333; Dec., p. 366
Biota Holdings Ltd. - Apr., p. 104; May, p. 140; Sep., p. 264; Dec., p. 366
Biotechnology Information Institute (BII) - Apr., p. 109
Biovector Therapeutics SA - May, p. 141; Dec., p. 361
Blick Medical Associates - June, p. 165
Blick Medical Group - Feb., p. 44
Boehringer Ingelheim Pharma KG - Sep., p. 269
Boehringer Ingelheim Pharmaceuticals, Inc. - Mar., p. 72; Aug., p. 225; Oct., p. 301
Boehringer Mannheim GmbH - Feb., p. 37 June, p. 166
Boston Biomedica, Inc. - Aug., p. 239
Bristol-Myers Squibb Co. - Feb., p. 33, 37; June, p. 170; Aug., p. 230, 233, 240
British Biotech Ltd. - Mar., p. 74
BTG International Inc. - Mar., p. 78; Oct., p. 303
Calgene, Inc. - July, p. 207
Calypte Biomedical Corp. - July, p. 204
Canadian Blood Services - Oct., p. 301
Cantab Pharmaceuticals PLC - Feb., p. 42 May, p. 130, 143
CEL-SCI Corp. - Aug., p. 237; Oct., p. 301
Cell Genesys, Inc. - Apr., p. 103; July, p. 195
Centeon - Dec., p. 359
Centers for AIDS Research (CFARs) - Sep., p. 269
Centers for Disease Control and Prevention (CDC) - Feb., p. 40; Mar., p. 73; Sep., p. 263; Oct., p. 300
Cerus Corp. - Feb., p. 36
Chemo Sero Therapeutic Research Inst. - Feb., p. 42
Child Health Corporation of America - Feb., p. 40
Chiron Behring GmbH & Co. - Apr., p. 107
Chiron Behring Vaccines Private Ltd. - May, p. 141
Chiron Corp. - Feb., p. 42, 43; Mar., p. 71, 72, 78; Apr., p. 107, 108; May, p. 133, 138; July, p. 204, 206; Aug., p. 234, 240; Sep., p. 271; Oct., p. 300; Nov., p. 323
Chiron Diagnostics Corp. - Aug., p. 237; Oct., p. 297
CIBA Vision Corp. - Mar., p. 65; Sep., p. 257
Cistron Biotechnology, Inc. - Mar., p. 73; Aug., p. 238; Nov., p. 330
Clinical Partners, Inc. - Oct., p. 299; Nov., p. 331
Colthurst Ltd. - Oct., p. 293
CONDEA Chemie GmbH - Nov., p. 333
Consortium for Plasma Science, LLC - Feb., p. 41
Corixa Corp. - Feb., p. 42
Cornell Univ. Medical Center - Feb., p. 43
Corvas International, Inc. - May, p. 141
CpG ImmunoPharmaceuticals, Inc. - Sep., p. 270
CSL Ltd. - July, p. 202
Cytokine Networks Inc. - July, p. 200
Daiichi Pure Chemicals Co., Ltd. - July, p. 206
Dana-Farber Cancer Inst. - Mar., p. 67; June, p. 171; Sep., p. 261
Dimethaid Research Inc. - Nov., p. 331
DuPont Merck Pharmaceutical Co. - Feb., p. 39, 44; Mar., p. 74
DuPont Pharmaceuticals Co. - May, p. 140 June, p. 164, 167, 171; Aug., p. 232;Oct., p. 289; Dec., p. 366
Edenland, Inc. - Oct., p. 293
Elan Corp. - Feb., p. 41; Mar., p. 78
Emory Univ. - June, p. 174; Aug., p. 236; Sep., p. 270
Endorex Corp. - Feb., p. 41; Mar., p. 78
Enzo Biochem Inc. - July, p. 207
Enzon, Inc. - Dec., p. 360
EnzyMed, Inc. - Sep., p. 266
Evans Medical - Mar., p. 71
Flamel Technologies - Nov., p. 325
Food and Drug Administration (FDA) - Sep., p. 263; Dec., p. 367
Genelabs Technologies, Inc. - Mar., p. 71; Oct., p. 302
Genentech, Inc. - July, p. 206; Oct., p. 303
Genetic Systems Corp. - July, p. 204
Genetix Pharmaceuticals - May, p. 143
Genzyme Transgenics Corp. - Aug., p. 229
Gilead Sciences, Inc. - Mar., p. 73; Apr., p. 101, 103; July, p. 200, 201; Aug., p. 240; Sep., p. 265; Oct., p. 300; Nov., p. 323; Dec., p. 367
Glaxo Wellcome Inc./plc - Feb., p. 34, 42, 44; Mar., p. 68, 70, 77; Apr., p. 97, 98, 100, 108; May, p. 130, 131, 138; July, p. 199, 203; Aug., p. 233, 237, 238; Sep., p. 264, 270; Oct., p. 291, 298, 301; Nov., p. 330, 332, 334; Dec., p. 353, 355, 357
Green Cross Corp. - May, p. 138
Harvard Univ. - Feb., p. 46; Mar., p. 67
Hayashibara Biochemical Laboratories Inc. - Apr., p. 106
HemispheRx Biopharma, Inc. - Apr., p. 104; Nov., p. 333
Hepatitis Action and Advocacy Coalition (HAAC) - Oct., p. 293
Herpetic Eye Disease Study Group - Aug., p. 231
Hoechst Marion Roussel - Mar., p. 77; Apr., p. 103, 107; May, p. 141; July, p. 195; Dec., p. 359
Hoffmann-La Roche Inc./Ltd. - Feb., p. 37, 38; Mar., p. 75, 78; July, p. 200, 203, 206; Aug., p. 226, 236; Oct., p. 292; Dec., p. 360
Hollis-Eden Pharmaceuticals, Inc. - Oct., p. 293
Hughes Inst. - May, p. 136; Sep., p. 265
ICN Pharmaceuticals, Inc. - May, p. 129, 138
Immune Response Corp. - Feb., p. 43, Mar., p. 70; Apr., p. 106; June, p. 163; Aug., p. 229 Nov., p. 327
Immunex Corp. - Mar., p. 67; Aug., p. 228
Immusol, Inc. - Apr., p. 107
Impfstoffwerk Dessau-Tornau, GmbH - Dec., p. 362
Innogenetics NV - Sep., p. 263
Institut de la Sante de de la Recherche Medicale (INSERM) - May, p. 141
Institute of Human Virology - Apr., p. 100; May, p. 136; July, p. 196
Inter-Company Collaboration (ICC) for AIDS Drug Dev. - Dec., p. 360
Interferon Sciences, Inc. - Feb., p. 39; Mar., p. 69; Apr., p. 99; Aug., p. 229
International AIDS Vaccine Initiative (IAVI) - Dec., p. 362
Isis Pharmaceuticals, Inc. - Feb., p. 41; Mar., p. 65; Apr., p. 99; June, p. 169; Sep., p. 257, 270; Dec., p. 367
Ivax Corp. - Feb., p. 44
Janssen Pharmaceutica International - Dec., p. 357
Johns Hopkins Univ. - Aug., p. 236; Sep., p. 266; Nov., p. 329
Johnson & Johnson - Oct., p. 296
King Faisal Foundation - Apr., p. 109
King Pharmaceuticals, Inc. - Mar., p. 70; Sep., p. 268
La Sapienza Univ. - July, p. 202
Laboratory Corporation of America Holdings - May, p. 139
LeukoSite, Inc. - Feb., p. 41
Lexigen Pharmaceuticals Corp. - July, p. 205
Lidak Pharmaceuticals Inc. - Feb., p. 37; Oct., p. 291; Nov., p. 333
LifeTECH Corp. - Nov., p. 332
Ligand Pharmaceuticals Inc. - June, p. 172
Lilly & Co., Eli - Aug., p. 240
Massachusetts Inst. of Technology - Mar., p. 78
Maxim Pharmaceuticals, Inc. - Feb., p. 36; Apr., p. 107; June, p. 169
MDS Panlabs - Mar., p. 71
Medeva PLC - Sep., p. 267; Nov., p. 331; Dec., p. 357
Medical Discoveries, Inc. - Oct., p. 294
Medical Research Council (U.K.) - Dec., p. 362
MediChem Research, Inc. - Mar., p. 72
Medicorp Inc. - June, p. 165
MedImmune, Inc. - Feb., p. 38, 40; July, p. 193; Sep., p. 267, 269; Oct., p. 297, 301, 303; Dec., p. 366
Meditech Pharmaceuticals, Inc. - July, p. 202
Merck & Co., Inc. - Mar., p. 75; Apr., p. 108; June, p. 169, 171; Oct., p. 295, 296
Molecular Simulations, Inc. - Nov., p. 332
Monsanto Co. - June, p. 170; July, p. 207; Nov., p. 331
Nabi - Apr., p. 105; May, p. 139; June, p. 173; Sep., p. 263; Oct., p. 300; Nov., p. 333
NaPro BioTherapeutics Inc. - Feb., p. 44
National Cancer Inst. (NCI) - Feb., p. 40; Apr., p. 101; Sep., p. 264
National Clinicians Post-Exposure Prophylaxis Hotline - Feb., p. 45
National Heart, Lung and Blood Inst. (NHLBI) - Feb., p. 35
National Hemophilia Foundation (NHF) - Dec., p. 365
National HIV/AIDS Treatment Survey - July, p. 196
National Inst. of Allergy and Infectious Diseases (NIAID) - July, p. 197; Aug., p. 230, 239; Sep., p. 258, 268, 269; Nov., p. 323
National Inst. of Child Health and Human Development (NICHD) - May, p. 141; Sep., p. 265
National Inst. of Health (NIH) - Feb., p. 46; Mar., p. 73; May, p. 142
National Public Health Inst. of Finland - Apr., p. 105
New York Blood Center - Mar., p. 78; May, p. 142; Oct., p. 303
Nippon Roche K.K. - July, p. 206
Northwestern Univ. Medical Center - July, p. 202
Novavax, Inc. - Mar., p. 73; May, p. 143
Oklahoma Medical Research Foundation - July, p. 206
OraVax, Inc. - July, p. 198; Nov., p. 331; Dec., p. 359
Oxford Univ. - Dec., p. 362
Oxo Chemie AG - Nov., p. 331
Pall Corp. - Apr., p. 108
Pantheon Inc. - May, p. 140
Parkedale Pharmaceuticals, Inc. - Mar., p. 70
Pasteur Merieux Connaught - Feb., p. 42; May, p. 133; Aug., p. 238; Oct., p. 303; Nov., p. 330; Dec., p. 359, 364
Pentose Pharmaceuticals, Inc. - May, p. 135
Peptide Therapeutics Group PLC - Sep., p. 267; Nov., p. 331
Peptimmune, Inc. - Mar., p. 67
Pfizer Inc. - Apr., p. 107
Pharma Pacific Management Pty. Ltd. - Oct., p. 297
Pharmacia & Upjohn - Mar., p. 66, 72; June, p. 171; Aug., p. 235, 240
Pharmacopeia, Inc. - July, p. 202
Picower Inst. for Medical Research - July, p. 200
PowderJect Pharmaceuticals PLC - Apr., p. 100
Procept, Inc. - June, p. 172; Nov., p. 334
Progenics Pharmaceuticals, Inc. - Feb., p. 38; July, p. 202
Protein Design Labs. - Feb., p. 37; June, p. 166; Sep., p. 270; Oct., p. 303
Protein Sciences Corp. - Mar., p. 73
RA Co. Ltd. - June, p. 172
Republican AIDS Center (Russia) - Sep., p. 265
Rhone-Poulenc Rorer - Dec., p. 359
Rhone-Poulenc SA - Dec., p. 359
Ribi ImmunoChem Research Inc. - Dec., p. 358
RiboGene, Inc. - Sep., p. 266
RiboTargets Ltd. - Nov., p. 332
Ribozyme Pharmaceuticals, Inc. - Feb., p. 43
Roche Molecular Systems Inc. - May, p. 141
Rockefeller Foundation - Dec., p. 362
Roxane Laboratories, Inc. - Mar., p. 72
R.P. Scherer Corp. - July, p. 203
Russian Federation - Aug., p. 235
Sanofi Diagnostics Pasteur - July, p. 204
Sarawak MediChem Pharmaceuticals, Inc. - Mar., p. 72
Schering-Plough Corp. - May, p. 129, 138, 141; July, p. 206; Aug., p. 229, 235; Sep., p. 266, 267; Oct., p. 293; Nov., p. 327, 333; Dec., p. 354, 360
Schering-Plough K.K. - Feb., p. 38; May, p. 134
SciClone Pharmaceuticals, Inc. - Feb., p. 38; Mar., p. 78; May, p. 134; Nov., p. 324
Scriptgen Pharmaceuticals, Inc. - Apr., p. 105
Seikagaku Corp. - Mar., p. 74
Sepracor Inc. - Mar., p. 72; Apr., p. 104
Shearwater Polymers, Inc. - Dec., p. 360
Shionogi & Co., Ltd. - Apr., p. 105; July, p. 205
Signal Pharmaceuticals, Inc. - Feb., p. 44
SmithKline Beecham Biologicals - June, p. 170; Dec., p. 358, 361
SmithKline Beecham Corp. - Feb., p. 38; May, p. 134; June, p. 172; Sep., p. 268, 271; Oct., p. 297, 302; Nov., p. 330
SmithKline Beecham PLC - Feb., p. 38; Apr., p. 109; Oct., p. 295
South Africa - Dec., p. 357
Southern Health SCD.BHD - Apr., p. 107
SRA Life Sciences - Oct., p. 299
SRI International - Mar., p. 71
St. Jude ChildrenŐs Research Hospital - Mar., p. 70
Stanford Univ. Medical Center - June, p. 171
Swedish Inst. for Infectious Disease Control - May, p. 137
Swiss Serum and Vaccine Inst. - June, p. 170
T Cell Sciences (use AVANT Immunotherapeutics, Inc.) - Oct., p. 295
Tanox Biosystems, Inc. - Sep., p. 270
Theratechnologies Inc. - Feb., p. 42; May, p. 143
Therion Biologics Corp. - Feb., p. 44; Sep., p. 261
Thermo BioAnalysis Corp. - Dec., p. 366
Tranzyme Pharmaceuticals Inc. - Nov., p. 335
Triangle Pharmaceuticals, Inc. - Feb., p. 34, 44; Mar., p. 76; Aug., p. 228; Nov., p. 332
Trimeris Inc. - Feb., p. 35; May, p. 140
Tripos, Inc. - Mar., p. 71; Apr., p. 104
United Cancer Research Inst. - June, p. 168
United Kingdom - Aug., p. 238
United Nations Programme on HIV/AIDS (UNAIDS) - Aug., p. 232
Univ. College London Medical School - Aug., p. 234
Univ. of Alabama - Aug., p. 236
Univ. of California, San Diego - Mar., p. 77; Apr., p. 106, 107
Univ. of Capetown - Dec., p. 362
Univ. of Georgia - Mar., p. 76
Univ. of Gtesborg - Apr., p. 107
Univ. of Maryland - Apr., p. 105; June, p. 173
Univ. of Missouri - Apr., p. 104
Univ. of Nairobi - Dec., p. 362
Univ. of North Carolina - Apr., p. 100; May, p. 136, 139; Aug., p. 239
Univ. of Wisconsin School of Veterinary Medicine - Sep., p. 266
Univ. Pierre et Marie Curie - July, p. 196
U.S. Army Medical Research Inst. of Infectious Diseases (USAMRIID) - Apr., p. 106; Dec., p. 362
U.S. Bioscience, Inc. - Apr., p. 101
U.S. Supreme Court - July, p. 203
V.I. Technologies, Inc. - Apr., p. 108, 109; May, p. 142; Dec., p. 365
VacTex, Inc. - May, p. 140
Vanderbilt Univ. - Mar., p. 71
Vanguard Biosciences Inc. - Nov., p. 332
Vanguard Medica - Dec., p. 364
VaxGen, Inc. - Mar., p. 71; June, p. 161; Sep., p. 268
Vertex Pharmaceuticals Inc. - Feb., p. 39; Aug., p. 240; Oct., p. 292
VIMRx Pharmaceuticals Inc. - Feb., p. 40
Viragen, Inc. - Apr., p. 107; Aug., p. 238; Oct., p. 300; Dec., p. 365
Virax Holdings Ltd. - Sep., p. 267
Virco Group - May, p. 139
ViroPharma Inc. - Nov., p. 326
Virus Research Inst. (use AVANT Immunotherapeutics, Inc.)
Warner-Lambert Co. - Feb., p. 41; Mar., p. 70; Aug., p. 238; Dec., p. 364
Wyeth-Ayerst Laboratories - Sep., p. 258; Dec., p. 364
Yale Univ. - Mar., p. 76
Zelinsky Inst. of the Russian Academy of Sciences - May, p. 135
Zeneca Group - Dec., p. 365
ZymeTx, Inc. - July, p. 206